Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China; College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Fitoterapia. 2022 Oct;162:105300. doi: 10.1016/j.fitote.2022.105300. Epub 2022 Sep 16.
Four pairs of undescribed chromane and chromene meroterpenoid scalemic mixtures (1a/1b-4a/4b), together with three pairs of known chromane meroterpenoid ones (5a/5b-7a/7b) were isolated from the twigs and leaves of Rhododendron dauricum L. Among them, 1a/1b-3a/3b and 5a/5b-7a/7b were the chromane ones derived from an intramolecular [2 + 2] cyclic addition of their respective chromene precursors, forming a 6/6/6/4 and 6/6/5/4 ring fused scaffold. The absolute configurations of the chiral center at C-15 of 2a/2b were determined by Snatzke's method, and comparing the experimental and calculated electronic circular dichroism (ECD) data. The inhibitory effects of the isolated compounds were tested against lipopolysaccharide (LPS)-induced nitric oxide production in RAW264.7 macrophage cells to evaluate their anti-inflammatory activity. Compounds 4a, 4b and 6a displayed inhibitory effects on nitric oxide (NO) production, and compound 4b exhibited the obvious anti-inflammatory activity, with an IC value of 6.91 ± 0.97 μM, by downregulating nuclear factor kappa B (NF-κB) and reducing the expression of inducible nitric oxide synthase (iNOS) in LPS-induced RAW264.7 cells. These results intimated that 4b could be used as a leading compound to develop anti-inflammatory drugs and is worthy of further investigated.
从苍山杜鹃的嫩枝和叶片中分离得到了四对未描述的色烯和色烯倍半萜类混合物(1a/1b-4a/4b),以及三对已知的色烯倍半萜类混合物(5a/5b-7a/7b)。其中,1a/1b-3a/3b 和 5a/5b-7a/7b 是各自色烯前体通过分子内[2+2]环加成形成的色烯类化合物,形成了 6/6/6/4 和 6/6/5/4 环融合骨架。2a/2b 中 C-15 手性中心的绝对构型通过 Snatzke 法确定,并通过比较实验和计算的电子圆二色性(ECD)数据。对分离得到的化合物进行了抗炎活性测试,以评估它们对脂多糖(LPS)诱导的 RAW264.7 巨噬细胞一氧化氮产生的抑制作用。化合物 4a、4b 和 6a 对一氧化氮(NO)的产生具有抑制作用,化合物 4b 表现出明显的抗炎活性,IC 值为 6.91±0.97μM,通过下调核因子 kappa B(NF-κB)和降低 LPS 诱导的 RAW264.7 细胞中诱导型一氧化氮合酶(iNOS)的表达。这些结果表明,4b 可以作为开发抗炎药物的先导化合物,值得进一步研究。